Evidence map›Paper›PMID 29168748›Full record

ArticleProteomes2017

Variety and Dynamics of Proteoforms in the Human Proteome: Aspects of Markers for Hepatocellular Carcinoma.

Stanislav Naryzhny, Victor Zgoda, Artur Kopylov, Elena Petrenko, Olga Kleist, Аlexander Archakov

Open access · goldAbstract read
In one paragraph

Article in Proteomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Quantitative Aspects of the Human Cell Proteome.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Stanislav NaryzhnyInstitute of Biomedical Chemistry, Pogodinskaya 10, Moscow 119121, Russia. snaryzhny@mail.ru.
Victor ZgodaInstitute of Biomedical Chemistry, Pogodinskaya 10, Moscow 119121, Russia. vic@ibmh.msk.su.
Artur KopylovInstitute of Biomedical Chemistry, Pogodinskaya 10, Moscow 119121, Russia. a.t.kopylov@gmail.com.ORCID 0000-0002-7199-372X
Elena PetrenkoInstitute of Biomedical Chemistry, Pogodinskaya 10, Moscow 119121, Russia. el.petrenko@bk.ru.
Olga KleistPetersburg Nuclear Physics Institute, National Research Center "Kurchatov Institute", Gatchina, Leningrad Region 188300, Russia. okleyst@mail.ru.
Аlexander ArchakovInstitute of Biomedical Chemistry, Pogodinskaya 10, Moscow 119121, Russia. archak@ibmc.msk.ru.
Institute of Biomedical Chemistry · RUPetersburg Nuclear Physics Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously developed an approach, where two-dimensional gel electrophoresis (2DE) was used, followed by sectional analysis of the whole gel using high-resolution nano-liquid chromatography-mass spectrometry (ESI LC-MS/MS). In this study, we applied this approach on the panoramic analysis of proteins and their proteoforms from normal (liver) and cancer (HepG2) cells. This allowed us to detect, in a single proteome, about 20,000 proteoforms coded by more than 4000 genes. A set of 3D-graphs showing distribution of these proteoforms in 2DE maps (profiles) was generated. A comparative analysis of these profiles between normal and cancer cells showed high variability and dynamics of many proteins. Among these proteins, there are some well-known features like alpha-fetoprotein (FETA) or glypican-3 (GPC3) and potential hepatocellular carcinoma (HCC) markers. More detailed information about their proteoforms could be used for generation of panels of more specific biomarkers.

Indexed as

2DEabundancebiomarkerdynamicsESI LC-MS/MSprotein species/proteoformproteome

Identifiers

PMID29168748
PMCPMC5748568
OpenAlexW2769833791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.